Corrigendum to: Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from EUROAPS registry

Alijotas-Reig, J. ; Esteve-Valverde, E. ; Ferrer-Oliveras, R. ; Sáez-, L. (Universidad de Zaragoza) ; Lefkou, E. ; Mekinian, A. ; Belizna, C. ; Ruffatti, A. ; Hoxha, A. ; Tincani, A. ; Nalli, C. ; Marozio, L. ; Maina, A. ; Espinosa, G. ; Ríos-Garcés, R. ; Cervera, R. ; Carolis, S.D. ; Monteleone, G. ; Latino, O. ; Udry, S. ; Llurba, E. ; Garrido-Gimenez, C. ; Trespidi, L. ; Gerosa, M. ; Chighizola, C.B. ; Rovere-Querini, P. ; Canti, V. ; Mayer-Pickel, K. ; Tabacco, S. ; Arnau, A. ; Trapé, J. ; Ruiz-Hidalgo, D. ; Sos, L. ; Farran-Codina, I.

Resumen: Rheumatology 2020;59:1306–1314. doi:https://doi.org/10.1093/rheumatology/kez419

In the original article, the affiliation of co-author Cecilia Beatrice Chighizola should have read: “Experimental Laboratory of Immunological and Rheumatologic Researches, Istituto Auxologico Italiano, IRCCS, Cusano Milanino, Milan, Italy”. These details have been corrected only in this corrigendum to preserve the published version of record.

Idioma: Inglés

DOI: 10.1093/rheumatology/keab659

Año: 2021

Publicado en: Rheumatology (Oxford) 60, 12 (2021), 5883
ISSN: 1462-0324

Factor impacto JCR: 7.046 (2021)

Categ. JCR: RHEUMATOLOGY rank: 6 / 34 = 0.176 (2021) - Q1 - T1

Factor impacto CITESCORE: 8.5 - Medicine (Q1)

Factor impacto SCIMAGO: 1.563 - Rheumatology (Q1) - Pharmacology (medical) (Q1)

Tipo y forma: (Versión definitiva)

Área (Departamento): Area Medicina (Dpto. Medicina, Psiqu. y Derm.)